Literature DB >> 33784235

Human vaccines & immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2021        PMID: 33784235      PMCID: PMC8018369          DOI: 10.1080/21645515.2021.1898888

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  8 in total

1.  Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.

Authors:  Diwakar Davar; Amiran K Dzutsev; Giorgio Trinchieri; Hassane M Zarour; John A McCulloch; Richard R Rodrigues; Joe-Marc Chauvin; Robert M Morrison; Richelle N Deblasio; Carmine Menna; Quanquan Ding; Ornella Pagliano; Bochra Zidi; Shuowen Zhang; Jonathan H Badger; Marie Vetizou; Alicia M Cole; Miriam R Fernandes; Stephanie Prescott; Raquel G F Costa; Ascharya K Balaji; Andrey Morgun; Ivan Vujkovic-Cvijin; Hong Wang; Amir A Borhani; Marc B Schwartz; Howard M Dubner; Scarlett J Ernst; Amy Rose; Yana G Najjar; Yasmine Belkaid; John M Kirkwood
Journal:  Science       Date:  2021-02-05       Impact factor: 47.728

2.  Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.

Authors:  Gal Markel; Ben Boursi; Erez N Baruch; Ilan Youngster; Guy Ben-Betzalel; Rona Ortenberg; Adi Lahat; Lior Katz; Katerina Adler; Daniela Dick-Necula; Stephen Raskin; Naamah Bloch; Daniil Rotin; Liat Anafi; Camila Avivi; Jenny Melnichenko; Yael Steinberg-Silman; Ronac Mamtani; Hagit Harati; Nethanel Asher; Ronnie Shapira-Frommer; Tal Brosh-Nissimov; Yael Eshet; Shira Ben-Simon; Oren Ziv; Md Abdul Wadud Khan; Moran Amit; Nadim J Ajami; Iris Barshack; Jacob Schachter; Jennifer A Wargo; Omry Koren
Journal:  Science       Date:  2020-12-10       Impact factor: 47.728

3.  Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.

Authors:  Kai Wu; Anne P Werner; Matthew Koch; Angela Choi; Elisabeth Narayanan; Guillaume B E Stewart-Jones; Tonya Colpitts; Hamilton Bennett; Seyhan Boyoglu-Barnum; Wei Shi; Juan I Moliva; Nancy J Sullivan; Barney S Graham; Andrea Carfi; Kizzmekia S Corbett; Robert A Seder; Darin K Edwards
Journal:  N Engl J Med       Date:  2021-03-17       Impact factor: 91.245

4.  COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

Authors:  Victoria Jane Hall; Sarah Foulkes; Ayoub Saei; Nick Andrews; Blanche Oguti; Andre Charlett; Edgar Wellington; Julia Stowe; Natalie Gillson; Ana Atti; Jasmin Islam; Ioannis Karagiannis; Katie Munro; Jameel Khawam; Meera A Chand; Colin S Brown; Mary Ramsay; Jamie Lopez-Bernal; Susan Hopkins
Journal:  Lancet       Date:  2021-04-23       Impact factor: 79.321

5.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

Authors:  Noa Dagan; Noam Barda; Eldad Kepten; Oren Miron; Shay Perchik; Mark A Katz; Miguel A Hernán; Marc Lipsitch; Ben Reis; Ran D Balicer
Journal:  N Engl J Med       Date:  2021-02-24       Impact factor: 91.245

6.  Neutralizing Activity of BNT162b2-Elicited Serum.

Authors:  Yang Liu; Jianying Liu; Hongjie Xia; Xianwen Zhang; Camila R Fontes-Garfias; Kena A Swanson; Hui Cai; Ritu Sarkar; Wei Chen; Mark Cutler; David Cooper; Scott C Weaver; Alexander Muik; Ugur Sahin; Kathrin U Jansen; Xuping Xie; Philip R Dormitzer; Pei-Yong Shi
Journal:  N Engl J Med       Date:  2021-03-08       Impact factor: 91.245

7.  Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.

Authors:  Robert Motzer; Boris Alekseev; Sun-Young Rha; Camillo Porta; Masatoshi Eto; Thomas Powles; Viktor Grünwald; Thomas E Hutson; Evgeny Kopyltsov; María J Méndez-Vidal; Vadim Kozlov; Anna Alyasova; Sung-Hoo Hong; Anil Kapoor; Teresa Alonso Gordoa; Jaime R Merchan; Eric Winquist; Pablo Maroto; Jeffrey C Goh; Miso Kim; Howard Gurney; Vijay Patel; Avivit Peer; Giuseppe Procopio; Toshio Takagi; Bohuslav Melichar; Frederic Rolland; Ugo De Giorgi; Shirley Wong; Jens Bedke; Manuela Schmidinger; Corina E Dutcus; Alan D Smith; Lea Dutta; Kalgi Mody; Rodolfo F Perini; Dongyuan Xing; Toni K Choueiri
Journal:  N Engl J Med       Date:  2021-02-13       Impact factor: 91.245

8.  Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Authors:  Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; Lily Y Weckx; Pedro M Folegatti; Parvinder K Aley; Brian Angus; Vicky L Baillie; Shaun L Barnabas; Qasim E Bhorat; Sagida Bibi; Carmen Briner; Paola Cicconi; Elizabeth A Clutterbuck; Andrea M Collins; Clare L Cutland; Thomas C Darton; Keertan Dheda; Christina Dold; Christopher J A Duncan; Katherine R W Emary; Katie J Ewer; Amy Flaxman; Lee Fairlie; Saul N Faust; Shuo Feng; Daniela M Ferreira; Adam Finn; Eva Galiza; Anna L Goodman; Catherine M Green; Christopher A Green; Melanie Greenland; Catherine Hill; Helen C Hill; Ian Hirsch; Alane Izu; Daniel Jenkin; Carina C D Joe; Simon Kerridge; Anthonet Koen; Gaurav Kwatra; Rajeka Lazarus; Vincenzo Libri; Patrick J Lillie; Natalie G Marchevsky; Richard P Marshall; Ana V A Mendes; Eveline P Milan; Angela M Minassian; Alastair McGregor; Yama F Mujadidi; Anusha Nana; Sherman D Padayachee; Daniel J Phillips; Ana Pittella; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Adam J Ritchie; Hannah Robinson; Alexandre V Schwarzbold; Andrew Smith; Rinn Song; Matthew D Snape; Eduardo Sprinz; Rebecca K Sutherland; Emma C Thomson; M Estée Török; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Thomas White; Christopher J Williams; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2021-02-19       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.